VSI Winter 2016 Newsletter
Bibliography and Sources
Back to Newsletter
Clinuvel. 2014 Announcements: Clinuvel’s Phase II vitiligo study commences in Singapore. May 6, 2014. http://www.clinuvel.com/en/investors/news-publications/announcements/2014-announcements/clinuvel%E2%80%99s-phase-ii-vitiligo-study-commences-in-singapore.
Clinuvel. 2015 Announcements: Positive preliminary results in Singaporean vitiligo study. December 3, 2015. http://www.clinuvel.com/en/investors/news-publications/announcements/2015-announcements/positive-preliminary-results-in-singaporean-vitiligo-study.
Clinuvel. 2015 Announcements: Update on North American vitiligo program for SCENESSE®. December 3, 2015. http://www.clinuvel.com/en/investors/news-publications/announcements/2015-announcements/update-on-north-american-vitiligo-program-for-scenesse.
Prystowsky JH, Keen MS, Rabinowitz AD, Stevens AW, DeLeo VA. Present status of eyelid phototherapy. Clinical efficacy and transmittance of ultraviolet and visible radiation through human eyelids. J Am Acad Dermatol. 1992 Apr;26(4):607-13.
Ramagopalan SV, Heger A, Berlanga AJ, Maugeri NJ, Lincoln MR, Burrell A, Handunnetthi L, Handel AE, Disanto G, Orton S, Watson CT, Morahan JM, Giovannoni G, Ponting CP, Ebers GC, Knight JC. (2010) A ChIP-seq-defined genome-wide map of vitamin D receptor binding: Associations with disease and evolution. Genome Res.doi:10.1101/gr.107920.110. http://genome.cshlp.org/site/press/gr107920.xhtml
Silverberg J, Silverberg A, Malka E, Silverberg N. A Pilot Study Assessing the Role of 25 Hydroxy Vitamin D Levels in Patients with Vitiligo Vulgaris. Journal of the American Academy of Dermatology. June 2010.
Spritz RA. The genetics of vitiligo. J Invest Dermatol 131: E18–E20. 17 November 2011. doi:10.1038/skinbio.2011.7.
Vitiligo Support International, Inc. Medical News Updates: Preliminary Scenesse: First Phase Results Look Promising For Combination Therapy For Vitiligo. VSI Winter 2012 Newsletter. http://newsletters.vitiligosupport.org/archive/winter2012/winter.html#medical.
Vitiligo Support International, Inc. Medical News Updates: SCENESSE® Phase 1 Trial Results Published. VSI Fall 2014 Newsletter.http://newsletters.vitiligosupport.org/archive/fall2014/fall.html#medical.
Wu S, Li WQ, et al. Use of permanent hair dyes and risk of vitiligo in women. Pigment Cell Melanoma Res. 2015 Nov;28(6):744-6. doi: 10.1111/pcmr. 12402. Epub Aug 20 2015. http://www.ncbi.nlm.nih.gov/pubmed/26212072.